Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02953769 · ClinicalTrials.gov registry record

Prevena Incision Management System Wound Care

A clinical trial, sponsored by AdventHealth.

Terminated
Registry status
61
Enrollment target

NCT02953769: Clinical Trial study, sponsored by AdventHealth.

NCT02953769 is a clinical trial that was terminated before completion, run by AdventHealth. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02953769 was terminated before completion, sponsored by AdventHealth.

TERMINATED
Registry status
61 participants
Enrollment target

Study Summary

Comparison of ventral hernia repair using standard wound care versus Prevena.

Primary Outcome

To quantify differences in the routine care of wound morbidity versus the use of Prevena™ by observing the healing process and obtaining quality of life by using the Carolinas Comfort Scale.

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2017-03-29
Est. Completion 2018-10-16
AdventHealth

95 total trials

Why NCT02953769 stopped before completion

NCT02953769 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02953769 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02953769 about?

NCT02953769 is a clinical study titled "Prevena Incision Management System Wound Care". Comparison of ventral hernia repair using standard wound care versus Prevena.

What is the current status of trial NCT02953769?

This trial is currently terminated. The enrollment target is 61 participants. The study started on 2017-03-29. Estimated completion is 2018-10-16.

Who is sponsoring clinical trial NCT02953769?

This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02953769, the US trial registry maintained by the National Library of Medicine. NCT02953769 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.